A MRSA Infection Cost Me $300,000—and Nearly Killed Me

This essay is part of a TIME series on the growing effects of antimicrobial resistance: superbugs that may no longer be treated with standard-course antibiotics. In 2016, World Health Organization leaders called drug resistance a "major global threat" estimated to kill 10 million people a year in 2050. This is the story of Chris Linaman, who survived a severe infection of the bacteria MRSA, which occurs most frequently in healthcare settings. The infection was resistant to antibiotics used to treat it.